MedTrace Logo

HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in Egypt

NCT03839979 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71975

Last updated 2021-03-18

No results posted yet for this study

Summary

An observational double-blind cohort study that examined the association between HCV viral hepatitis, blood sugar level and systolic blood pressure in the Egyptian population

Conditions

Interventions

DIAGNOSTIC_TEST

BIOLINE HCV kits

We used BIOLINE HCV kits to detect the presence of HCV antibodies in stick blood samples of all recruited patients.

DIAGNOSTIC_TEST

ACCU-CHEK kits

For all patients, we measured random blood sugar levels by stick blood samples using ACCU-CHEK kits.

DIAGNOSTIC_TEST

ErKameter 3000 mercury manometer

For all patients, we measured systolic blood pressure using ErKameter 3000 mercury manometer.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2018-12-31
Completion
2019-01-31
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03839979 on ClinicalTrials.gov